Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The changing landscape of intestinal transplantation: Insights from the first quarter of the 21st century of Eurotransplant experience.

Intestinal Failure (New York, N.Y.)·2026
Same author

ASO Visual Abstract: Improved Clinical Outcomes in Anastomotic Leak Management Using Preemptive Endoscopic Vacuum Therapy after Esophagectomy.

Annals of surgical oncology·2026
Same author

Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.

Journal of the National Cancer Institute·2026
Same author

Perioperative outcomes of robotic-assisted liver surgery: A comparison between patients with and without previous abdominal surgery.

Surgery open science·2026
Same author

Conversion to LCP Tacrolimus Mitigates Calcineurin-Induced Nephrotoxicity in Patients After Liver Transplantation.

Clinical transplantation·2026
Same author

[Esophageal NEN: update on diagnostics and surgical treatment].

Chirurgie (Heidelberg, Germany)·2026

Related Experiment Video

Updated: Jun 28, 2026

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
05:03

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy

Published on: April 17, 2020

Donor brain death significantly interferes with tolerance induction protocols.

Maja Francuski1, Anja Reutzel-Selke, Sascha Weiss

  • 1Department of General, Visceral, and Transplantation Surgery, Charité, Campus Virchow Clinic, Universitätsmedizin Berlin, Germany.

Transplant International : Official Journal of the European Society for Organ Transplantation
|October 29, 2008
PubMed
Summary

Donor brain-death significantly impacts kidney transplant tolerance. Anti-CD4 antibodies improved tolerance in living donor grafts but not in brain-dead donor grafts, highlighting the importance of donor condition for successful transplantation.

More Related Videos

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 28, 2026

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy
05:03

Brain Death Induction in Mice Using Intra-Arterial Blood Pressure Monitoring and Ventilation via Tracheostomy

Published on: April 17, 2020

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Area of Science:

  • Immunology
  • Transplantation Biology
  • Nephrology

Background:

  • Antibodies can induce allograft tolerance in rodent models.
  • Clinical organ transplant outcomes remain suboptimal, with deceased donors being the primary source.
  • The impact of donor brain-death on transplant tolerance is not well understood.

Purpose of the Study:

  • To investigate the effect of donor brain-death on tolerance induction after experimental kidney transplantation.
  • To compare the efficacy of anti-CD4 monoclonal antibodies (RIB 5/2) in inducing tolerance in grafts from brain-dead versus living donors.

Main Methods:

  • Experimental kidney transplantation in a rat model (F344-to-Lewis).
  • Groups included recipients of grafts from brain-dead or living donors, treated with anti-CD4 antibodies (RIB 5/2) or untreated, all receiving low-dose Cyclosporine A (CsA).
  • Graft assessment included morphology, immunohistology, flow cytometry, and renal function monitoring up to 40 weeks.

Main Results:

  • RIB 5/2 treatment significantly reduced proteinuria and improved graft function in living donor allograft recipients.
  • In living donor grafts, RIB 5/2 treatment led to reduced inflammatory cell infiltration and MHC class II expression, with minimal morphologic changes at 40 weeks.
  • In contrast, RIB 5/2 treatment had no significant impact on graft function, structural integrity, or inflammatory infiltration in brain-dead donor allograft recipients.

Conclusions:

  • Donor brain-death status critically affects the efficacy of anti-CD4 antibody-induced tolerance in kidney transplantation.
  • While anti-CD4 antibodies show promise for improving outcomes with living donor grafts, they are ineffective in the context of brain-dead donor organs.
  • Strategies to overcome tolerance induction barriers in brain-dead donor kidney transplantation require further investigation.